Latest News

New Clinical Guideline on Injectable Opioid Agonist Treatment for Severe Opioid Use Disorder

The Canadian Research Initiative in Substance Misuse National Injectable Opioid Agonist Treatment Steering Committee has released a new guideline.

Buprenorphine for Substance Use Disorder: Is Certification Right for Your Practice?

There is enormous need for well-trained providers who are educated in treating opioid use disorder.

Opioid Epidemic: Is Overdose More Likely if a Family Member Has a Prescription?

Investigators examined whether opioid overdose is more likely if a family member has a prescription. We review their findings.

Lofexidine May Effectively Mitigate Symptoms of Opioid Withdrawal Syndrome

Treatment with lofexidine may provide better control of the symptoms of opioid withdrawal syndrome compared with placebo.

USPSTF Finds Evidence Lacking to Prevent Illicit Drug Use in Youth

The USPSTF finds that the current evidence is insufficient to recommend primary care-based interventions to prevent illicit drug use in children, adolescents, and young adults.

Problematic Alcohol, Cannabis Consumption and Opioid Misuse in Chronic Pain

Participants with current moderate to severe chronic pain and opioid use were assessed for substance abuse problems.

Calling for an Overhaul of Buprenorphine Policy for More Comprehensive Addiction Treatment

The authors suggest that removing X-waiver requirements would allow healthcare providers to better assist patients with opioid use disorder.

Post-Detoxification Primary Care Treatment Linked to Reduced Illicit Opioid Use

Linkage to office-based buprenorphine treatment reduced illicit opioid use and increased days of buprenorphine treatment in patients discharged from a short-term detoxification program.

US Surgeon General Warns of Marijuana’s Effect on Brain Development

Marijuana use is risky for young people and pregnant women.

E-Cigarettes Associated With Increased Marijuana Use in Adolescents

Investigators noted a significant increase in the odds of concurrent and subsequent marijuana use in adolescents and young adults who used e-cigarettes.